- Launch of new allergen-blocking nasal spray in Austria for the treatment of hay fever complements existing OTC product portfolio
- Partner M8 Pharmaceuticals launches Carragelose nasal spray for the treatment of viral respiratory infections in Mexico
- Further value maximization and revenue potential for Carragelose asset
The full press release is available as download here: